Growing a backbone - functional biomaterials and structures for intervertebral disc (IVD) repair and regeneration: challenges, innovations, and future directions.


Journal

Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571

Informations de publication

Date de publication:
03 Mar 2020
Historique:
pubmed: 21 1 2020
medline: 29 9 2020
entrez: 21 1 2020
Statut: ppublish

Résumé

Back pain and associated maladies can account for an immense amount of healthcare cost and loss of productivity in the workplace. In particular, spine related injuries in the US affect upwards of 5.7 million people each year. The degenerative disc disease treatment almost always arises due to a clinical presentation of pain and/or discomfort. Preferred conservative treatment modalities include the use of non-steroidal anti-inflammatory medications, physical therapy, massage, acupuncture, chiropractic work, and dietary supplements like glucosamine and chondroitin. Artificial disc replacement, also known as total disc replacement, is a treatment alternative to spinal fusion. The goal of artificial disc prostheses is to replicate the normal biomechanics of the spine segment, thereby preventing further damage to neighboring sections. Artificial functional disc replacement through permanent metal and polymer-based components continues to evolve, but is far from recapitulating native disc structure and function, and suffers from the risk of unsuccessful tissue integration and device failure. Tissue engineering and regenerative medicine strategies combine novel material structures, bioactive factors and stem cells alone or in combination to repair and regenerate the IVD. These efforts are at very early stages and a more in-depth understanding of IVD metabolism and cellular environment will also lead to a clearer understanding of the native environment which the tissue engineering scaffold should mimic. The current review focusses on the strategies for a successful regenerative scaffold for IVD regeneration and the need for defining new materials, environments, and factors that are so finely tuned in the healthy human intervertebral disc in hopes of treating such a prevalent degenerative process.

Identifiants

pubmed: 31957773
doi: 10.1039/c9bm01288e
doi:

Substances chimiques

Biocompatible Materials 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216-1239

Commentaires et corrections

Type : ErratumIn

Auteurs

Matthew D Harmon (MD)

Department of Materials Science and Engineering, University of Connecticut, Storrs, CT, USA. Kumbar@uchc.edu and Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA.

Daisy M Ramos (DM)

Department of Materials Science and Engineering, University of Connecticut, Storrs, CT, USA. Kumbar@uchc.edu and Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA.

D Nithyadevi (D)

Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA.

Rosalie Bordett (R)

Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA.

Swetha Rudraiah (S)

Department of Pharmaceutical Sciences, University of Saint Joseph, Hartford, CT, USA.

Syam P Nukavarapu (SP)

Department of Materials Science and Engineering, University of Connecticut, Storrs, CT, USA. Kumbar@uchc.edu and Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA and Department of Biomedical Engineering, University of Connecticut, Storrs, CT, USA.

Isaac L Moss (IL)

Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA.

Sangamesh G Kumbar (SG)

Department of Materials Science and Engineering, University of Connecticut, Storrs, CT, USA. Kumbar@uchc.edu and Department of Orthopedics Surgery, University of Connecticut Health, Farmington, CT, USA and Department of Biomedical Engineering, University of Connecticut, Storrs, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH